Militia Capital Partners’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$873K Buy
29,601
+15,717
+113% +$427K 0.33% 98
2025
Q3
$359K Sell
13,884
-11,600
-46% -$324K 0.17% 137
2025
Q2
$703K Buy
25,484
+20,484
+410% +$539K 0.33% 88
2025
Q1
$142K Buy
+5,000
New +$177K 0.11% 111

Other funds holding MRNA

Militia Capital Partners's MRNA Position: Q4 2025 in Review

Militia Capital Partners increased its Moderna (MRNA) stake by 113% in Q4 2025, buying an estimated $427K and bringing the position to 29,601 shares worth $873K. The position accounts for 0.33% of the portfolio, ranked #98.

Militia Capital Partners first reported a position in MRNA in Q1 2025 and has held it in 4 quarters since. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Militia Capital Partners held 29,601 shares of Moderna worth $873K as of Q4 2025.
  • Militia Capital Partners bought 15,717 Moderna shares in Q4 2025, an estimated $427K.
  • Moderna made up 0.33% of Militia Capital Partners's portfolio in Q4 2025, its #98 holding.
  • Militia Capital Partners first reported a position in Moderna in Q1 2025 and has held it in 4 quarters since.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.